title: Scanning mutagenesis studies reveal a potential intramolecular interaction within the C-terminal half of dengue virus NS2A involved in viral RNA replication and virus assembly and secretion.
abstract: The NS2A protein of dengue virus (DENV) has eight predicted transmembrane segments (pTMSs; pTMS1 to pTMS8). NS2A has been shown to participate in RNA replication, virion assembly, and the host antiviral response. However, the role of the amino acid residues within the pTMS regions of NS2A during the virus life cycle is poorly understood. In the study described here, we explored the function of DENV NS2A by introducing a series of double or triple alanine substitutions into the C-terminal half (pTMS4 to pTMS8) of NS2A in the context of a DENV infectious clone or subgenomic replicon. Fourteen (8 within pTMS8) of 35 NS2A mutants displayed a lethal phenotype due to impairment of RNA replication by a replicon assay. Three NS2A mutants with mutations within pTMS7, the CM20, CM25, and CM27 mutants, displayed similar phenotypes, low virus yields (>100-fold reduction), wild-type-like replicon activity, and low infectious virus-like particle yields by transient trans-packaging experiments, suggesting a defect in virus assembly and secretion. The sequencing of revertant viruses derived from CM20, CM25, and CM27 mutant viruses revealed a consensus reversion mutation, leucine (L) to phenylalanine (F), at codon 181 within pTMS7. The introduction of an L181F mutation into a full-length NS2A mutant, i.e., the CM20, CM25, and CM27 constructs, completely restored wild-type infectivity. Notably, L181F also substantially rescued the other severely RNA replication-defective mutants with mutations within pTMS4, pTMS6, and pTMS8, i.e., the CM2, CM3, CM13, CM31, and CM32 mutants. In conclusion, the results revealed the essential roles of pTMS4 to pTMS8 of NS2A in RNA replication and/or virus assembly and secretion. The intramolecular interaction between pTMS7 and pTMS4, pTMS6, or pTMS8 of the NS2A protein was also implicated.
  
  
  OBJECTIVE
  The reported characterization of the C-terminal half of dengue virus NS2A is the first comprehensive mutagenesis study to investigate the function of flavivirus NS2A involved in the steps of the virus life cycle. In particular, detailed mapping of the amino acid residues within the predicted transmembrane segments (pTMSs) of NS2A involved in RNA replication and/or virus assembly and secretion was performed. A revertant genetics study also revealed that L181F within pTMS7 is a consensus reversion mutation that rescues both RNA replication-defective and virus assembly- and secretion-defective mutants with mutations within the other three pTMSs of NS2A. Collectively, these findings elucidate the role played by NS2A during the virus life cycle, possibly through the intricate intramolecular interaction between pTMS7 and other pTMSs within the NS2A protein.
authors: Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli, Taiwan, Republic of China Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, Republic of China.
authors: Ren-Huang
authors: RH
authors: Wu
authors: Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli, Taiwan, Republic of China.
authors: Ming-Han
authors: MH
authors: Tsai
authors: Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung Hsing University, Taichung, Republic of China.
authors: Day-Yu
authors: DY
authors: Chao
authors: Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli, Taiwan, Republic of China Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, Republic of China andrewyueh@nhri.org.tw.
authors: Andrew
authors: A
authors: Yueh
mesh_terms: D001483:Base Sequence; D015153:Blotting, Western; D017931:DNA Primers / Q000235:genetics; D003716:Dengue Virus / Q000235:genetics / Q000378:metabolism*; D004797:Enzyme-Linked Immunosorbent Assay; D004926:Escherichia coli; D057809:HEK293 Cells; D006801:Humans; D008969:Molecular Sequence Data; D016296:Mutagenesis; D012441:Saccharomyces cerevisiae; D017422:Sequence Analysis, DNA; D017361:Viral Nonstructural Proteins / Q000235:genetics / Q000378:metabolism*; D010948:Viral Plaque Assay; D019065:Virus Assembly / Q000235:genetics / Q000502:physiology*; D014779:Virus Replication / Q000235:genetics / Q000502:physiology*
chemical_list: D017931:DNA Primers; C079341:NS2A protein, Dengue virus type 2; D017361:Viral Nonstructural Proteins
references: J Gen Virol. 2014 Jul;95(Pt 7):1493-503
references: 24728712
references: J Gen Virol. 2013 Feb;94(Pt 2):308-13
references: 23114626
references: J Virol. 2015 Jan 15;89(2):1298-313
references: 25392211
references: J Virol. 2013 Apr;87(8):4609-22
references: 23408612
references: Antiviral Res. 2013 May;98(2):228-41
references: 23499649
references: Lancet Infect Dis. 2002 Jan;2(1):33-42
references: 11892494
references: J Virol. 2002 May;76(10):4773-84
references: 11967294
references: J Virol. 2003 Jul;77(14):7804-13
references: 12829820
references: Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14333-8
references: 14612562
references: Int J Infect Dis. 2004 Mar;8(2):69-80
references: 14732325
references: J Virol. 2004 Nov;78(22):12225-35
references: 15507609
references: Bull World Health Organ. 1980;58(1):1-21
references: 6966540
references: Science. 1985 Aug 23;229(4715):726-33
references: 4023707
references: J Clin Microbiol. 1985 Aug;22(2):250-4
references: 4031038
references: Virology. 1989 Mar;169(1):100-9
references: 2922923
references: Am J Trop Med Hyg. 1989 Jun;40(6):571-8
references: 2472746
references: Am J Trop Med Hyg. 1989 Nov;41(5):576-80
references: 2817214
references: Epidemiol Bull. 1989;10(1):1-8
references: 2484241
references: Annu Rev Microbiol. 1990;44:649-88
references: 2174669
references: J Virol. 1991 May;65(5):2467-75
references: 2016768
references: J Virol. 1995 Nov;69(11):7232-43
references: 7474145
references: J Mol Biol. 1996 Jul 19;260(3):289-98
references: 8757792
references: Virology. 1997 Apr 14;230(2):300-8
references: 9143286
references: World Health Stat Q. 1997;50(3-4):161-9
references: 9477544
references: Virology. 1998 Jun 5;245(2):203-15
references: 9636360
references: J Biol Chem. 1998 Jul 17;273(29):18060-6
references: 9660762
references: J Virol. 1999 Aug;73(8):6257-64
references: 10400716
references: J Virol. 2005 Feb;79(3):1934-42
references: 15650219
references: J Virol. 2006 Mar;80(5):2396-404
references: 16474146
references: Virology. 2007 Jul 20;364(1):184-95
references: 17382364
references: J Virol. 2008 May;82(10):4731-41
references: 18337583
references: Antimicrob Agents Chemother. 2011 Jan;55(1):229-38
references: 20937790
references: J Virol. 2011 Jul;85(14):6963-76
references: 21543474
references: J Virol. 2011 Aug;85(16):8158-71
references: 21680530
references: N Engl J Med. 2012 Apr 12;366(15):1423-32
references: 22494122
references: J Virol. 2012 Oct;86(19):10347-58
references: 22787234
references: J Virol. 2014 Sep;88(18):10813-30
references: 25008922